NCT07321990 Study of the Reproducibility of the French Version of the Modified SMAFRS Scale Status RECRUITING Phase N/A
NCT07047144 A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy Status RECRUITING Phase PHASE2
NCT06877689 EAP of Apitegromab for Patients With Spinal Muscular Atrophy Status NO_LONGER_AVAILABLE Phase N/A
NCT06322654 A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal Muscular Atrophy) Patients Status RECRUITING Phase NA
NCT06300996 Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb Status ACTIVE_NOT_RECRUITING Phase NA
NCT05626855 Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05337553 A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05156320 Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam Status COMPLETED Phase PHASE3
NCT04825119 Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen Status UNKNOWN Phase N/A
NCT04042025 Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03921528 An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy Status COMPLETED Phase PHASE2
NCT03461289 Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 Status COMPLETED Phase PHASE3
NCT02941328 SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4 Status COMPLETED Phase PHASE2
NCT00774423 Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE2/PHASE3